Phio Pharmaceuticals
PHIO
PHIO
11 hedge funds and large institutions have $387K invested in Phio Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$114K |
2 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.9K |
3 |
VF
Virtu Financial
New York
|
+$34K |
4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8K |
5 |
SS
SBI Securities
Tokyo,
Japan
|
+$2.21K |
Top Sellers
1 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$14.1K |
2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$14K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.25K |
4 |
UBS Group
Zurich,
Switzerland
|
-$134 |